The Performance of Quantiferon TB Gold In-Tube as a Screening Tool in Paediatric Rheumatology prior to Initiation of Infliximab: A Single Centre's Experience
ISRN Rheumatology · 2011
DOI: 10.5402/2011/505171 ↗Kurz gefasst
Fachartikel in der Zeitschrift ISRN Rheumatology, 2011. Verfasst von Despoina Maritsi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Academic Department of Paediatric and Adolescent Rheumatology, Great Ormond Street Hospital and Institute of Child Health, London WC1N 3JH, UK. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Abstract (Originalsprache)
Background
Patients with autoimmune diseases and latent tuberculosis infection (LTBI) are at risk of developing catastrophic tuberculosis disease following infliximab treatment. Quantiferon-TB gold in-Tube (QTB) has proven a more accurate screening tool than tuberculin skin test (TST) in adult populations.
Objectives
To assess the utility and validity of QTB in children, prior to treatment with infliximab.
Methods
Retrospective cohort of patients started on infliximab following endorsement of QTB as a screening tool by the NICE guidelines in 2006.
Results
Twenty three patients (12 females and 11 males) were included in the study. A chest radiograph (CXR) and QTB was performed prior to starting infliximab. Fourteen patients had a recorded negative TST result. One patient had a positive QTB while two had indeterminate results. Their CXRs were not suggestive of TB and TSTs were negative. The patients with indeterminate results were started on infliximab and had regular clinical assessment for TB disease. Repeat QTB was negative in one while remained indeterminate in the other. None of our 23 patients developed TB.
Conclusion
QTB is a useful screen tool for LTBI. Indeterminate results warrant careful assessment and re-evaluation, but should not preclude from initiation of anti TNF treatment.
Autor:innen und Institutionen
- Academic Department of Paediatric and Adolescent Rheumatology, Great Ormond Street Hospital and Institute of Child Health, London WC1N 3JH, UK.
Zitieren
APA
Maritsi, D., Al-Obadi, M., Brogan, P. A., Eleftheriou, D., & Dixon, G. L. (2011). The Performance of Quantiferon TB Gold In-Tube as a Screening Tool in Paediatric Rheumatology prior to Initiation of Infliximab: A Single Centre's Experience. ISRN Rheumatology. https://doi.org/10.5402/2011/505171
Vancouver
Maritsi D, Al-Obadi M, Brogan PA, Eleftheriou D, Dixon GL. The Performance of Quantiferon TB Gold In-Tube as a Screening Tool in Paediatric Rheumatology prior to Initiation of Infliximab: A Single Centre's Experience. ISRN Rheumatology. 2011. doi:10.5402/2011/505171
BibTeX
@article{Maritsi2011,
author = {Maritsi, Despoina and Al-Obadi, Muthana and Brogan, Paul A and Eleftheriou, Despina and Dixon, Garth L J},
title = {The Performance of Quantiferon TB Gold In-Tube as a Screening Tool in Paediatric Rheumatology prior to Initiation of Infliximab: A Single Centre's Experience},
journal = {ISRN Rheumatology},
year = {2011},
doi = {10.5402/2011/505171}
}
EUVIMED